The first Chinese Biopharmaceutical Association (CBA) China Annual Conference has concluded and Apeloa is proud to have been recognized as a "Vice-Chairman Enterprise". This accolade highlights our dedication and contributions to the industry's progress. We are grateful for the insights gained and the connections formed, which will support our mission of "Technology for Health".
Dr. Daniel Xu's presentation on peptide drug advancements stirred significant interest and reflected on our deep expertise in improving drug stability and efficacy. Apeloa also spotlighted our strategic partnership with Zencore Biologics to create a comprehensive ADC CDMO service.
We look forward to future CBA conferences, continuing our journey of discovery and progress together.
